|Summary of 8 sections of eCRF and site questionnaire|
|Site Questionnaire||Enrollment||Demographics||Information on AF||Medical treatment Prior to enrollment||Diagnostic Procedures||Acute Treatment of AF||Discharge||Follow-up at 60 days|
|Center characteristics (type, size, units)||Demographics (age, gender, ethnicity)||Anthropometrics (ht, wt, bp)||Current episode (symptoms, type, time of onset, triggers)||ATT, rate control, other (type, indication, dose)||Laboratory measures (Hg, K, sCr, PG, INR-T)||AA/Rate control (type, dose),||Basics (vital status, date, time, destination)||Contact information (mode, date)|
|Specialties at site (clinics, physicians, number and availability, procedures available)||Admission information (date, time, site, reason)||Medical history (CVD, CHF, details thereof)||History of AF (date, frequency, nature, treatment)||ECG (rhythm, rate, PR & QT interval, QRS duration, LVH)||PCV & ECV (labs before, after, type, dose/joules & number of shocks route, worked?, time to SR, SR after)||Rhythm at discharge; LoS by unit||Basics (vital status, current rhyuthm)|
|Most frequent and most preferred approach to cardioversion||ECG information (date, time, results)||History of risk factors (family hx of disease, DM, smoking, htn, hyperlipidemia)||TTE (LA size, LVEDD, LV-EF, LVH)||Catheter ablation (type, technique, location, status), pacemaker, ICD implantation (type, indication)||Complications and AEs experienced (specified, date)||Recurrence and rehospitalization since discharge (date, LoS, documentation, CV info., reason)|
|Other comorbidities||TEE (findings)||Surgery (time, date, location, technique)||Discharge medications (type, dose, indication)||Complications and AEs experienced (specified, date)|
|Chest X-Ray, Stress test, Holter ECG, MRI, CT exam||Discharge medications (type, dose, indication)|
eCRF: electronic case report form; AF: atrial fibrillation; ht: height; wt: weight; bp: blood pressure; ATT: antithrombotic treatment; Hg: mercury; K: potassium; sCr: serum creatinine; PG: plasma glucose; INR-T: International Normalized Ratio (Prothombin Time); CVD: cardiovascular disease; CHF: congestive heart failure; ECG: electrocardiogram; PCV: pharmacologic cardioversion; ECV: electrical cardioversion; SR: sinus rhythm; LoS: length of stay; DM: diabetes mellitus; TTE: transthoracic echocardiogram; LA: left atrium; LVEDD: left ventricular end diastolic diameter; LV-EF: left ventricular ejection fraction; LVH: left ventricular hypertrophy; ICD: implantable cardioverter-defibrillator; AEs: adverse events; TEE: transesophageal echocardiogram; MRI: magnetic resonance imaging.
Crijns et al.
Crijns et al. BMC Cardiovascular Disorders 2012 12:85 doi:10.1186/1471-2261-12-85